Terry Hermiston
30Patents
7h-index
22Co-inventors
69Inventor score
Filing activity: Dec 27, 1999 → Jun 9, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7550296B2 | Generation of replication competent viruses for therapeutic use | Chemistry; Metallurgy | 49 | Expired |
| US6723316B2 | Herpes simplex virus-1 Glycoprotein C mutants for treating unwanted hyperproliferative cell growth | Chemistry; Metallurgy | 34 | Expired |
| US7510868B2 | Chimeric adenoviruses for use in cancer treatment | Chemistry; Metallurgy | 30 | Expired |
| US7001596B1 | Oncolytic adenovirus | Chemistry; Metallurgy | 26 | Expired |
| US8216819B2 | Generation of oncolytic adenoviruses and uses thereof | Chemistry; Metallurgy | 21 | Active |
| US7078030B2 | Oncolytic adenovirus | Chemistry; Metallurgy | 10 | Expired |
| US8765463B2 | Chimeric adenoviruses for use in cancer treatment | Chemistry; Metallurgy | 9 | Active |
| US6764674B1 | Adenovirus E1B shuttle vectors | Chemistry; Metallurgy | 5 | Expired |
| US8158599B2 | Chimeric adenoviruses for use in cancer treatment | Chemistry; Metallurgy | 5 | Active |
| US6635244B2 | Adenovirus E1B-55K single amino acid mutants and methods of use | Chemistry; Metallurgy | 4 | Expired |
| US9694048B2 | Gla domains as targeting agents | Emerging Cross-Sectional Technologies | 3 | Active |
| US7396679B2 | Oncolytic adenovirus | Chemistry; Metallurgy | 3 | Expired |
| US9593166B2 | Monoclonal antibodies against antithrombin β | Chemistry; Metallurgy | 2 | Active |
| US10894075B2 | Gla domains as targeting agents | Emerging Cross-Sectional Technologies | 2 | Active |
| US10717970B2 | Short-acting factor VII polypeptides | Human Necessities | 1 | Active |
| US10925926B2 | GLA domains as therapeutic agents | Emerging Cross-Sectional Technologies | 1 | Active |
| US9908942B2 | Monoclonal antibodies against antithrombin β | Chemistry; Metallurgy | 1 | Active |
| US6660259B2 | Herpes simplex virus for treating unwanted hyperproliferative cell growth | Chemistry; Metallurgy | 1 | Expired |
| US9115337B2 | Chimeric adenoviruses for use in cancer treatment | Chemistry; Metallurgy | 1 | Active |
| US11981723B2 | Method of targeting exosomes | Emerging Cross-Sectional Technologies | 0 | Active |
| US9034344B2 | Chimeric adenoviruses for use in cancer treatment | Chemistry; Metallurgy | 0 | Active |
| US11530401B2 | Short-acting Factor VII polypeptides | Human Necessities | 0 | Active |
| US7829329B2 | Adenoviral vectors for treating disease | Chemistry; Metallurgy | 0 | Expired |
| US8882484B2 | Methods and compositions for production of recombinant protein in HBX-expressing mammalian cells | Chemistry; Metallurgy | 0 | Active |
| US9234185B2 | Chimeric adenoviruses for use in cancer treatment | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.